INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New targeted pill tested as next hope for Tough-to-Treat liver cancer
Disease control Not yet recruitingThis study is for adults with advanced bile duct cancer (intrahepatic cholangiocarcinoma) that has a specific genetic change (FGFR2) and has gotten worse after their first round of treatment. It will compare a new oral tablet called TT-00420 to standard chemotherapy to see which …
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: PHASE3 • Sponsor: TransThera Sciences (Nanjing), Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New test aims to perfect timing for liver cancer surgery
Disease control Not yet recruitingThis study is for people with a type of advanced liver cancer called intrahepatic cholangiocarcinoma. It tests whether a new evaluation system (TDTP-RECIST) can better guide doctors on when to perform surgery after patients have received initial drug therapy (GOLP regimen). The g…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Three-Pronged attack on tough liver cancer
Disease control Not yet recruitingThis study is testing a three-part treatment for advanced bile duct cancer that cannot be removed by surgery. It combines targeted chemotherapy delivered directly to the liver with two drugs taken by mouth and through an IV. The goal is to see if this combination can shrink tumor…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New scan could make liver cancer treatment safer for lungs
Diagnosis Not yet recruitingThis study is testing a new way to check if a radioactive liver cancer treatment called radioembolization is safe for a patient's lungs. Currently, doctors use a different test particle that can overestimate lung risk and has supply issues. Researchers will give 30 patients a sma…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Diagnosis
Last updated Apr 04, 2026 06:51 UTC
-
New scan aims to spare cancer patients unnecessary surgery
Diagnosis Not yet recruitingThis study is testing an improved ultrasound method to check if bile duct cancer has spread to nearby lymph nodes before surgery. It will observe 250 patients to see if this better scan can accurately identify patients who should not undergo a major operation because the cancer h…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Sponsor: Erasmus Medical Center • Aim: Diagnosis
Last updated Apr 02, 2026 14:56 UTC